Without the return of the product, no definitive conclusion can be made regarding the clinical observation.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information that 11 years 10 months post implant of this mitral bioprosthetic valve, the patient presented with worsening dyspnea on exertion, severe mitral insufficiency, and a torn leaflet of the mitral bioprosthetic valve.A transesophageal echocardiogram (tee) also indicated severe tricuspid regurgitation, mild to moderate aortic insufficiency, and moderate right ventricular systolic dysfunction.The physician explanted and replaced the mitral bioprosthetic valve.During this procedure, the physician also repaired the patient's native tricuspid valve with an annuloplasty ring and replaced the patient's native aortic valve with a bioprosthetic valve.No other adverse patient effects were reported.Patient medical history: thrombocytopenic.
|